Moreover we recently demonstrated that galectin-3 immunotargeting represents an useful diagnostic tool for identifying preoperatively malignant thyroid proliferations on immuno-cytological bases, although some thyroid carcinomas (about 10–15% depending by the studies) do not express galectin-3 [10]–[14], [17]. This evidence concerns the gene LGALS3 and thyroid gland carcinoma.